RNS Number : 7211J Long Path Partners LP 01 December 2025

RNS 編號：7211J Long Path Partners LP2025年12月1日

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

不得在任何法律或法規的相關管轄區內，全部或部分，直接或間接發佈、出版或分發此公告。

FOR IMMEDIATE RELEASE

立即發佈

1 December 2025

2025年12月1日

RECOMMENDED CASH ACQUISITION

推薦現金收購

由

Idox plc

由

Frankel UK Bidco Limited

(a newly-formed company indirectly owned by Long Path Co-Investment Fund #6, LP (acting by its general partner, Long Path Co-Investment Fund #6 GP, LLC), Long Path Smaller Companies Fund, LP (acting by its general partner Long Path Fund GP, LLC), Long Path Smaller Companies Master Fund, Ltd. and Long Path Opportunities Fund II, LP (acting by its general partner, Long Path Opportunities Fund GP, LLC))

（一家由 Long Path Co-Investment Fund #6, LP（通過其普通合夥人 Long Path Co-Investment Fund #6 GP, LLC）、Long Path Smaller Companies Fund, LP（通過其普通合夥人 Long Path Fund GP, LLC）、Long Path Smaller Companies Master Fund, Ltd.和 Long Path Opportunities Fund II, LP（通過其普通合夥人 Long Path Opportunities Fund GP, LLC）間接擁有的新成立公司）

Update on Letters of Intent

意向書更新

On 28 October 2025 the boards of directors of Frankel UK Bidco Limited ("Bidco"), a newly-formed company to be indirectly owned by Long Path Co-Investment Fund #6, LP (acting by its general partner, Long Path Co-Investment Fund #6 GP, LLC), Long Path Smaller Companies Fund, LP (acting by its general partner Long Path Fund GP, LLC), Long Path Smaller Companies Master Fund, Ltd. and Long Path Opportunities Fund II, LP (acting by its general partner, Long Path Opportunities Fund GP, LLC), and Idox plc ("Idox") made an announcement pursuant to Rule 2.7 of the Takeover Code (the "Rule 2.7 Announcement") of a recommended all-cash acquisition by Bidco of the entire issued, and to be issued, ordinary share capital of Idox (the "Acquisition"), intended to be implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act (the "Scheme").

2025年10月28日，Frankel UK Bidco Limited（"Bidco"）的董事會（該公司將由 Long Path Co-Investment Fund #6, LP（通過其普通合夥人 Long Path Co-Investment Fund #6 GP, LLC）、Long Path Smaller Companies Fund, LP（通過其普通合夥人 Long Path Fund GP, LLC）、Long Path Smaller Companies Master Fund, Ltd.和 Long Path Opportunities Fund II, LP（通過其普通合夥人 Long Path Opportunities Fund GP, LLC）間接擁有）與 Idox plc（"Idox"）根據收購守則第 2.7 條發佈了一項公告（"第 2.7 條公告"），建議 Bidco 以現金收購 Idox 的全部已發行及待發行普通股資本（"收購"），計劃通過根據《公司法》第 26 部分的法院批准安排實施（"方案"）。

Unless otherwise defined in this announcement, capitalised words and phrases used in this announcement shall have the same meanings given to them in the Rule 2.7 Announcement.

除非在本公告中另有定義，否則本公告中使用的資本化詞彙和短語應具有第 2.7 條公告中賦予它們的相同含義。

As set out in Appendix 3 to the Rule 2.7 Announcement, Bidco had received irrevocable undertakings and non-binding letters of intent from certain Idox Shareholders to vote in favour (or, where applicable, procure voting) of the Scheme at the Court Meeting and the Resolutions to be proposed at the General Meeting (or, in the event that the Acquisition is implemented by way of an Offer, to accept or procure the acceptance of the Offer), in respect of a total of 106,033,494 Idox Shares, representing approximately 22.97 per cent. of the existing issued ordinary share capital of Idox as at 27 October 2025, being the last Business Day before the date of the Rule 2.7 Announcement. These include a non-binding letter of intent from Rathbones Investment Management ("Rathbones") in respect of 35,203,152 Idox Shares, representing approximately 7.62 per cent. of the existing issued ordinary share capital of Idox as at 27 October 2025, being the last Business Day before the date of the Rule 2.7 Announcement (the "Rathbones Letter of Intent").

如第 2.7 條公告附錄 3 所述，Bidco 已收到某些 Idox 股東的不可撤銷承諾和非約束性意向書，支持在法院會議上投票贊成（或在適用情況下，促成投票）該方案，以及在股東大會上提出的決議（或在收購通過要約實施的情況下，接受或促成接受要約），涉及總計 106,033,494 股 Idox 股份，約佔截至2025年10月27日（即第 2.7 條公告發布前的最後一個工作日）Idox 現有已發行普通股資本的 22.97%。其中包括來自 Rathbones Investment Management（"Rathbones"）的非約束性意向書，涉及 35,203,152 股 Idox 股份，約佔截至2025年10月27日（即第 2.7 條公告發布前的最後一個工作日）Idox 現有已發行普通股資本的 7.62%（"Rathbones 意向書"）。

Under the Rathbones Letter of Intent, Rathbones is permitted to sell, acquire or otherwise deal in Idox Shares at any time.

根據 Rathbones 意向書，Rathbones 被允許在任何時間出售、收購或以其他方式處理 Idox 股份。

Since the Rule 2.7 Announcement:

自第 2.7 條公告以來：

1. On 2 November 2025, Mission Trail Capital Management LLC delivered to Bidco an executed non-binding letter of intent to vote in favour of the Scheme at the Court Meeting and the Resolutions to be proposed at the General Meeting (or, in the event that the Acquisition is implemented by way of an Offer, to accept the Offer) in respect of 13,830,107 Idox Shares;

1.2025年11月2日，Mission Trail Capital Management LLC 向 Bidco 提交了一份已簽署的非約束性意向書，支持在法院會議上投票贊成該方案以及在股東大會上提出的決議（或在收購通過要約實施的情況下，接受要約），涉及 13,830,107 股 Idox 股份；

2. On 4 November 2025, Richard H. Witmer Jr. delivered to Bidco an executed non-binding letter of intent to vote in favour of the Scheme at the Court Meeting and the Resolutions to be proposed at the General Meeting (or, in the event that the Acquisition is implemented by way of an Offer, to accept the Offer) in respect of 10,003,818 Idox Shares;

2.2025年11月4日，Richard H. Witmer Jr.向 Bidco 提交了一份已簽署的非約束性意向書，支持在法院會議上投票贊成該方案以及在股東大會上提出的決議（或在收購通過要約實施的情況下，接受要約），涉及 10,003,818 股 Idox 股份；

3. Rathbones has notified Bidco that, on 28, 29, 30, 31 October and 3, 4, 5, 6, 7, 10, 11, 12, 13, 17, 18, 19, 20, 21, 24, 25, 26 and 27 November 2025, it had sold certain Idox Shares that were previously subject to the Rathbones Letter of Intent; and

Rathbones 已通知 Bidco，在 2025 年 10 月 28、29、30、31 日及 11 月 3、4、5、6、7、10、11、12、13、17、18、19、20、21、24、25、26 和 27 日，它已出售某些之前受 Rathbones 意向書約束的 Idox 股份；以及

4. On 6 November 2025, Mercia Fund Management Limited delivered to Bidco an executed non-binding letter of intent to vote in favour of the Scheme at the Court Meeting and the Resolutions to be proposed at the General Meeting (or, in the event that the Acquisition is implemented by way of an Offer, to accept the Offer) in respect of 7,528,333 Idox Shares.

4.2025年11月6日，Mercia Fund Management Limited 向 Bidco 提交了一份已簽署的非約束性意向書，支持在法院會議上投票贊成該方案以及在股東大會上提出的決議（或在收購通過要約實施的情況下，接受要約），涉及 7,528,333 股 Idox 股份。

As a result:

因此：

· the total number of Idox Shares which are subject to the Rathbones Letter of Intent has reduced to 32,519,392 Idox Shares, representing approximately 7.04 per cent. of the existing issued share capital of Idox as at close of business on 28 November 2025, being the last Business Day prior to the date of this announcement; and

· 根據截至2025年11月28日（即本公告發布前的最後一個工作日）收盤時的數據，受 Rathbones 意向書約束的 Idox 股份總數已減少至 32,519,392 股，約佔 Idox 現有已發行股本的 7.04%；以及

· the total number of Idox Shares which are subject to irrevocable undertakings and non-binding letters of intent has, in aggregate, since the Rule 2.7 Announcement, increased from 106,033,494 to 134,711,992 Idox Shares, representing approximately 29.17 per cent. of the issued share capital of Idox as at close of business on 28 November 2025, being the last Business Day prior to this announcement.

· 自第 2.7 條公告以來，受不可撤銷承諾和非約束性意向書約束的 Idox 股份總數已從 106,033,494 股增加至 134,711,992 股，約佔截至2025年11月28日（即本公告發布前的最後一個工作日）Idox 已發行股本的 29.17%。

In addition to this, Long Path currently holds 56,876,997 Idox Shares, representing approximately 12.32 per cent. of the issued share capital of Idox as at close of business on 28 November 2025, being the last Business Day prior to this announcement.

此外，Long Path 目前持有 56,876,997 股 Idox 股份，約佔截至2025年11月28日（即本公告發布前的最後一個工作日）Idox 已發行股本的 12.32%。

The Company remains in an 'offer period' in accordance with the rules of the Code and the attention of Scheme Shareholders is drawn to the continuing disclosure requirements of Rule 8 of the Code, which are summarised below.

根據守則的規定，公司仍處於 “要約期”，並提醒方案股東注意守則第 8 條的持續披露要求，具體內容如下。

Enquiries

諮詢


Bidco and Long Path Will Brennan Brian Nelson John Cresson Kyle Warren	via Canaccord Genuity
Canaccord Genuity Limited (Financial Adviser to Bidco and Long Path)	+ 44 (0) 20 7523 8000
Simon Bridges Max Hartley Harry Rees
Idox Chris Stone, Non-Executive Chair David Meaden, Chief Executive Officer Anoop Kang, Chief Financial Officer	+44 (0) 333 011 1200
N.M. Rothschild & Sons Limited (Lead Financial Adviser to Idox) Warner Mandel Anton Black Jose Benito Sanz	+44 (0) 20 7280 5000
Peel Hunt LLP (Joint Financial Adviser and Corporate Broker to Idox) Neil Patel Benjamin Cryer Kate Bannatyne Alice Lane	+44 (0) 20 7418 8900
MHP (PR Adviser to Idox) Reg Hoare Ollie Hoare Finn Taylor idox@mhpgroup.com	+ 44 (0) 7831 406 117


Bidco 和 Long Path Will Brennan Brian Nelson John Cresson Kyle Warren	通過 Canaccord Genuity
Canaccord Genuity Limited（Bidco 和 Long Path 的財務顧問）	+ 44 (0) 20 7523 8000
Simon Bridges Max Hartley Harry Rees
Idox Chris Stone，非執行主席 David Meaden，首席執行官 Anoop Kang，首席財務官	+44 (0) 333 011 1200
N.M. Rothschild & Sons Limited（Idox 的首席財務顧問） Warner Mandel Anton Black Jose Benito Sanz	+44 (0) 20 7280 5000
Peel Hunt LLP（Idox 的聯合財務顧問和企業經紀人） Neil Patel Benjamin Cryer Kate Bannatyne Alice Lane	+44 (0) 20 7418 8900
MHP（Idox 的公關顧問） Reg Hoare Ollie Hoare Finn Taylor idox@mhpgroup.com	+ 44 (0) 7831 406 117

Kirkland & Ellis International LLP is acting as legal adviser to Bidco and Long Path.

Kirkland & Ellis International LLP 正在擔任 Bidco 和 Long Path 的法律顧問。

Pinsent Masons LLP is acting as legal adviser to Idox.

Pinsent Masons LLP 正在擔任 Idox 的法律顧問。

Further information

更多信息

Canaccord Genuity Limited, which is authorised and regulated by the FCA in the United Kingdom ("Canaccord"), is acting exclusively as financial adviser to Long Path and Bidco and no one else in connection with the Acquisition and will not be responsible to anyone other than Long Path and Bidco for providing the protections afforded to clients of Canaccord nor for providing advice in relation to the Offer or any other matters referred to in this announcement. Neither Canaccord nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Canaccord in connection with this announcement, any statement contained herein or otherwise.

Canaccord Genuity Limited，受英國金融行為監管局（"Canaccord"）授權和監管，正在作為 Long Path 和 Bidco 的獨家財務顧問，且不對其他任何人負責與本次收購相關的事務，並且不會對 Long Path 和 Bidco 以外的任何人提供 Canaccord 客户所享有的保護或提供與本公告中提到的要約或其他事項相關的建議。Canaccord 及其任何附屬機構對任何非 Canaccord 客户在與本公告、其中包含的任何聲明或其他方面相關的情況下，不承擔或接受任何責任、義務或責任（無論是直接還是間接，無論是合同、侵權、法定或其他）。

Rothschild & Co, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser to Idox and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than Idox for providing the protections afforded to clients of Rothschild & Co nor for providing advice in connection with the Acquisition or any matter referred to in this announcement. Neither Rothschild & Co nor any of its group undertakings or affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild & Co in connection with this announcement, any statement contained herein, the Acquisition or otherwise. No representation or warranty, express or implied, is made by Rothschild & Co as to the contents of this announcement.

Rothschild & Co，受英國金融行為監管局授權和監管，正在作為 Idox 的獨家財務顧問，且不對其他任何人負責與本公告主題相關的事務，並且不會對 Idox 以外的任何人提供 Rothschild & Co 客户所享有的保護或提供與本次收購或本公告中提到的任何事項相關的建議。Rothschild & Co 及其任何集團公司或附屬機構（或其各自的董事、高管、員工或代理人）對任何非 Rothschild & Co 客户在與本公告、其中包含的任何聲明、收購或其他方面相關的情況下，不承擔或接受任何責任、義務或責任（無論是直接還是間接，無論是合同、侵權、法定或其他）。Rothschild & Co 對本公告內容不作任何明示或暗示的陳述或保證。

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the UK by the FCA, is acting as joint financial adviser and corporate broker to Idox in connection with the Acquisition and shall not be responsible to anyone other than Idox for providing the protections afforded to clients of Peel Hunt nor for providing advice in connection with the Acquisition or any matter referred to herein. Neither Peel Hunt nor any of its group undertakings or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Peel Hunt in connection with the Acquisition n or any matter referred to herein.

Peel Hunt LLP（"Peel Hunt"），受英國金融行為監管局授權和監管，正在作為 Idox 的聯合財務顧問和企業經紀人，且不對其他任何人負責與本次收購相關的事務，並且不會對 Idox 以外的任何人提供 Peel Hunt 客户所享有的保護或提供與本次收購或本公告中提到的任何事項相關的建議。Peel Hunt 及其任何集團公司或附屬機構對任何非 Peel Hunt 客户在與本次收購或本公告中提到的任何事項相關的情況下，不承擔或接受任何責任、義務或責任（無論是直接還是間接，無論是合同、侵權、法定或其他）。

This announcement is for information purposes only and is not intended to, and does not, constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities of Idox in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely pursuant to the terms of the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the offer document), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any vote in respect of the Scheme or other response in relation to the Acquisition should be made only on the basis of the information contained in the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the offer document).

本公告僅供信息參考，不構成或形成任何要約、邀請或購買、獲取、認購、出售或以其他方式處置任何證券的要約或邀請，也不構成在任何司法管轄區內根據本次收購或其他事項的投票或批准的徵求，亦不應在任何司法管轄區內違反適用法律而出售、發行或轉讓 Idox 的證券。本次收購將僅根據方案文件的條款實施（或者，如果本次收購通過要約實施，則根據要約文件），其中將包含本次收購的完整條款和條件，包括如何就本次收購進行投票的詳細信息。任何關於方案或與本次收購相關的其他回應應僅基於方案文件中的信息（或者，如果本次收購通過要約實施，則基於要約文件）。

This announcement does not constitute a prospectus, prospectus equivalent document or exempted document.

本公告不構成招股説明書、招股説明書等效文件或豁免文件。

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

如果您對本公告的內容或應採取的行動有任何疑問，建議您立即向您的股票經紀人、銀行經理、律師、會計師或根據《2000 年金融服務和市場法》（經修訂）在英國獲得適當授權的獨立財務顧問尋求獨立的財務建議；如果您不在英國，則應向其他適當授權的獨立財務顧問尋求建議。

Overseas Shareholders

海外股東

The release, publication or distribution of this announcement in or into jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the law of any jurisdiction other than the UK should inform themselves of, and observe, any applicable legal or regulatory requirements. Any failure to comply with such requirements may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. This announcement has been prepared in accordance with and for the purpose of complying with English law, the Takeover Code, the AIM Rules, the Market Abuse Regulation and the Disclosure Guidance and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

本公告在英國以外的司法管轄區的發佈、出版或分發可能受到法律限制，因此任何受英國以外的任何司法管轄區法律約束的人員應自行了解並遵守任何適用的法律或監管要求。未能遵守這些要求可能構成對任何此類司法管轄區證券法的違反。在適用法律允許的最大範圍內，參與收購的公司和個人對任何人違反這些限制不承擔任何責任或義務。本公告已根據英國法律、收購守則、AIM 規則、市場濫用法規以及信息披露和透明度規則的要求進行準備，所披露的信息可能與根據英國以外的司法管轄區法律準備的信息不同。

The availability of the Acquisition to Idox Shareholders who are not resident in and citizens of the UK may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Persons who are not resident in the UK should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. Any person (including, without limitation, nominees, trustees and custodians) who would, or otherwise intends to, forward this announcement, the Scheme Document or any accompanying document to any jurisdiction outside the UK should refrain from doing so and seek appropriate professional advice before taking any action. In particular, the ability of persons who are not resident in the United Kingdom to vote their Scheme Shares with respect to the Scheme at the Court Meeting, or to appoint another person as proxy to vote at the Court Meeting on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. Further details in relation to Overseas Shareholders will be contained in the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the offer document).

不居住於英國且不是英國公民的 Idox 股東對收購的可用性可能會受到其所在司法管轄區或其國籍的相關法律的影響。非英國居民應自行了解並遵守其司法管轄區的任何適用法律或監管要求。任何人（包括但不限於提名人、受託人和保管人）如果打算將本公告、計劃文件或任何附帶文件轉發至英國以外的任何司法管轄區，應避免這樣做，並在採取任何行動之前尋求適當的專業建議。特別是，非英國居民在法院會議上投票其計劃股份的能力，或委任他人作為代理人在法院會議上代表其投票，可能會受到其所在司法管轄區法律的影響。未能遵守適用的限制可能構成對任何此類司法管轄區證券法的違反。在適用法律允許的最大範圍內，參與收購的公司和個人對任何人違反這些限制不承擔任何責任或義務。有關海外股東的進一步細節將包含在計劃文件中（或者，如果收購通過要約實施，則在要約文件中）。

Unless otherwise determined by Bidco or required by the Takeover Code, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into, from, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of, any Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Scheme by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including, without limitation, agents, custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of an Offer (unless otherwise permitted by applicable law and regulation), the Offer may not be made directly or indirectly, in, into, from, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of, any Restricted Jurisdiction and the Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.

除非 Bidco 另行決定或根據收購守則要求，並且在適用法律和法規允許的情況下，收購將不會直接或間接地通過郵件或任何手段或工具（包括但不限於傳真、電子郵件或其他電子傳輸、電話或電報）在任何限制性司法管轄區內、外進行，若這樣做會違反該司法管轄區的法律，任何人不得通過任何此類使用、手段、工具或在限制性司法管轄區內或任何其他司法管轄區內投票支持該計劃。如果這樣做會構成對該司法管轄區法律的違反，則不得在限制性司法管轄區內或從中直接或間接地郵寄或以其他方式轉發、分發或發送本公告及與收購相關的任何正式文件，接收此類文件的人員（包括但不限於代理人、保管人、提名人和受託人）不得在限制性司法管轄區內或從中郵寄或以其他方式轉發、分發或發送此類文件。這樣做可能使與收購相關的任何投票無效。如果收購通過要約實施（除非適用法律和法規另有允許），則該要約不得直接或間接地通過郵件或任何手段或工具（包括但不限於傳真、電子郵件或其他電子傳輸、電話或電報）在任何限制性司法管轄區內、外進行，且該要約可能無法通過任何此類使用、手段、工具或設施被接受。

Further details in relation to Overseas Shareholders will be included in the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the offer document).

有關海外股東的進一步細節將包含在計劃文件中（或者，如果收購通過要約實施，則在要約文件中）。

Notice to U.S. Idox Shareholders

致美國 Idox 股東的通知

The Acquisition relates to the shares of an English company and is being made by means of a scheme of arrangement provided for under English law. A transaction effected by means of a scheme of arrangement is not subject to the tender offer or proxy solicitation rules under the U.S. Securities Exchange Act of 1934 (the "U.S. Exchange Act"). Accordingly, the Acquisition is subject to the disclosure requirements and practices applicable in the UK to schemes of arrangement which differ from the disclosure requirements of the U.S. tender offer and proxy solicitation rules. The financial information included in this announcement has been prepared in accordance with generally accepted accounting principles of the United Kingdom and thus may not be comparable to financial information of U.S. companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States.

本次收購涉及一家英國公司的股份，並通過英國法律規定的安排計劃進行。通過安排計劃進行的交易不受 1934 年美國證券交易法（"美國交易法"）下的要約收購或代理徵求規則的約束。因此，本次收購受適用於英國安排計劃的披露要求和實踐的約束，這與美國要約收購和代理徵求規則的披露要求不同。本公告中包含的財務信息是根據英國公認會計原則編制的，因此可能與美國公司或根據美國公認會計原則編制財務報表的公司的財務信息不可比。

If, in the future, Bidco exercises its right to implement the Acquisition by way of an Offer, which is to be made into the United States, such Offer will be made in compliance with the applicable U.S. laws and regulations.

如果 Bidco 在未來行使其通過要約實施收購的權利，並且該要約將進入美國，則該要約將遵守適用的美國法律和法規。

It may be difficult for U.S. holders of Idox Shares to enforce their rights and any claim arising out of the U.S. federal laws, since Bidco and Idox are located in a non-U.S. jurisdiction, and some or all of their officers and directors may be residents of a non-U.S. jurisdiction. U.S. holders of Idox may not be able to sue a non-U.S. company or its officers or directors in a non-U.S. court for violations of the U.S. securities laws. Further, it may be difficult to compel a non-U.S. company and its affiliates to subject themselves to a U.S. court's judgement.

美國的 Idox 股東可能難以根據美國聯邦法律強制執行其權利和任何索賠，因為 Bidco 和 Idox 位於非美國司法管轄區，並且他們的部分或全部高管和董事可能是非美國司法管轄區的居民。美國的 Idox 股東可能無法在非美國法院對非美國公司或其高管或董事提起訴訟，以追究其違反美國證券法的責任。此外，強制非美國公司及其附屬公司接受美國法院的判決可能也會很困難。

In accordance with normal UK practice and pursuant to Rule 14e-5(b) of the U.S. Exchange Act, Long Path or their nominees, or their brokers (acting as agents), may from time to time make certain purchases of, or arrangements to purchase, Idox Shares outside of the U.S., other than pursuant to the Acquisition, until the date on which the Acquisition becomes Effective, lapses or is otherwise withdrawn. Also, in accordance with Rule 14e-5(b) of the U.S. Exchange Act, Canaccord will continue to act as an exempt principal trader in Idox Shares on the London Stock Exchange. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any information about such purchases will be disclosed as required in the United Kingdom, will be reported to a Regulatory Information Service and will be available on the London Stock Exchange website, www.londonstockexchange.com.

根據英國的正常慣例以及美國《證券交易法》第 14e-5(b) 條款，Long Path 或其提名人，或其經紀人（作為代理人）可能會不時在美國以外購買或安排購買 Idox 股份，除非根據收購協議，直到收購生效、失效或以其他方式撤回的日期。此外，根據美國《證券交易法》第 14e-5(b) 條款，Canaccord 將繼續在倫敦證券交易所作為 Idox 股份的豁免主要交易商。這些購買可能在公開市場以現行價格進行，或在私下交易中以協商價格進行。關於這些購買的任何信息將根據英國的要求披露，並將報告給監管信息服務，並將在倫敦證券交易所網站 www.londonstockexchange.com 上提供。

U.S. Idox Shareholders also should be aware that the transaction contemplated herein may have tax consequences for U.S. federal income tax purposes and under applicable U.S. state and local, as well as foreign and other, tax laws and, that such consequences, if any, are not described herein. U.S. Idox Shareholders are urged to consult with legal, tax and financial advisers in connection with making a decision regarding this transaction.

美國的 Idox 股東還應注意，此交易可能對美國聯邦所得税以及適用的美國州和地方税法、外國及其他税法產生税務影響，並且這些影響（如有）在此未作描述。建議美國的 Idox 股東在做出與此交易相關的決策時諮詢法律、税務和財務顧問。

Forward looking statements

前瞻性聲明

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Acquisition, and other information published by Bidco and Idox contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Bidco and Idox about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

本公告（包括本公告中引用的信息）、關於收購的口頭聲明以及 Bidco 和 Idox 發佈的其他信息包含可能被視為 “前瞻性聲明” 的陳述。前瞻性聲明具有前瞻性，基於當前的期望和 Bidco 和 Idox 管理層對未來事件的預測，而不是基於歷史事實，因此受到風險和不確定性的影響，這可能導致實際結果與前瞻性聲明所表達或暗示的未來結果存在重大差異。

The forward-looking statements contained in this announcement include statements relating to the expected effects of the Acquisition on Bidco and Idox (including their future prospects, developments and strategies), the expected timing and scope of the Acquisition and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "prepares", "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "projects", "synergy", "strategy", "scheduled", "goal", "estimates", "forecasts", "cost-saving", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements may include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Bidco's, Idox's, any member of the Bidco Group's or any member of the Idox Group's operations and potential synergies resulting from the Acquisition; and (iii) the effects of global economic conditions and governmental regulation on Bidco's, Idox's, any member of the Bidco Group's or any member of the Idox Group's business.

本公告中包含的前瞻性聲明包括與收購對 Bidco 和 Idox 的預期影響（包括它們的未來前景、發展和戰略）、收購的預期時間和範圍以及其他非歷史事實的聲明。通常，但並非總是，前瞻性聲明可以通過使用 “準備”、“計劃”、“期望” 或 “不期望”、“預計”、“受制於”、“預算”、“項目”、“協同效應”、“戰略”、“計劃”、“目標”、“估計”、“預測”、“節省成本”、“打算”、“預期” 或 “不預期” 或 “相信”，或這些詞和短語的變體，或某些行動、事件或結果 “可能”、“可以”、“應該”、“會”、“可能” 或 “將” 被採取、發生或實現來識別。前瞻性聲明可能包括與以下內容相關的聲明：（i）未來的資本支出、費用、收入、收益、協同效應、經濟表現、債務、財務狀況、股息政策、損失和未來前景；（ii）業務和管理戰略以及 Bidco、Idox、Bidco 集團的任何成員或 Idox 集團的任何成員的運營擴展和增長，以及收購帶來的潛在協同效應；以及（iii）全球經濟條件和政府監管對 Bidco、Idox、Bidco 集團的任何成員或 Idox 集團的任何成員業務的影響。

Although Bidco and Idox believe that the expectations reflected in such forward-looking statements are reasonable, Bidco and Idox can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements.

儘管 Bidco 和 Idox 相信這些前瞻性聲明中反映的期望是合理的，但 Bidco 和 Idox 無法保證這些期望將被證明是正確的。由於前瞻性聲明涉及未來將發生的事件並依賴於未來的情況，因此本質上涉及風險和不確定性。有許多因素可能導致實際結果和發展與這些前瞻性聲明所表達或暗示的結果存在重大差異。

These factors include, but are not limited to: the ability to complete the Acquisition; the ability to obtain requisite regulatory and shareholder approvals and the satisfaction of other Conditions on the proposed terms and schedule; changes in the global political, economic, business and competitive environments and in market and regulatory forces; changes in future exchange and interest rates; changes in tax rates; future business combinations or disposals; changes in general economic and business conditions; changes in the behaviour of other market participants; changes in the anticipated benefits from the proposed transaction not being realised as a result of changes in general economic and market conditions in the countries in which Bidco and Idox operate, weak, volatile or illiquid capital and/or credit markets, changes in tax rates, interest rate and currency value fluctuations, the degree of competition in the geographic and business areas in which Bidco and Idox operate and changes in laws or in supervisory expectations or requirements. Other unknown or unpredictable factors could cause actual results to differ materially from those expected, estimated or projected in the forward-looking statements. If any one or more of these risks or uncertainties materialises or if any one or more of the assumptions proves incorrect, actual results may differ materially from those expected, estimated or projected. Such forward-looking statements should therefore be construed in the light of such factors. Neither Bidco nor Idox, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place any reliance on these forward-looking statements.

這些因素包括但不限於：完成收購的能力；獲得必要的監管和股東批准的能力，以及滿足提議條款和時間表的其他條件；全球政治、經濟、商業和競爭環境以及市場和監管力量的變化；未來匯率和利率的變化；税率的變化；未來的業務合併或處置；一般經濟和商業條件的變化；其他市場參與者行為的變化；由於所在國家的整體經濟和市場條件變化，導致預期的交易收益未能實現；資本和/或信貸市場疲軟、波動或流動性不足；税率、利率和貨幣價值波動的變化；Bidco 和 Idox 所處的地理和業務領域的競爭程度；以及法律或監管期望或要求的變化。其他未知或不可預測的因素可能導致實際結果與預期、估計或預測的結果有重大差異。如果這些風險或不確定性中的任何一個或多個實現，或者任何一個或多個假設被證明不正確，實際結果可能與預期、估計或預測的結果有重大差異。因此，這些前瞻性聲明應在考慮這些因素的情況下進行解讀。Bidco 和 Idox 及其各自的關聯方、董事、高級職員或顧問均不對本公告中任何前瞻性聲明所表達或暗示的事件的發生提供任何陳述、保證或擔保。請謹慎對待這些前瞻性聲明。

Specifically, statements of estimated cost savings and synergies related to future actions and circumstances which, by their nature, involve risks, uncertainties and contingencies. As a result, the cost savings and synergies referred to may not be achieved, may be achieved later or sooner than estimated, or those achieved could be materially different from those estimated. Due to the scale of the Idox Group, there may be additional changes to the Idox Group's operations. As a result, and given the fact that the changes relate to the future, the resulting cost synergies may be materially greater or less than those estimated.

具體而言，關於未來行動和情況的成本節約和協同效應的估計聲明，其本質上涉及風險、不確定性和偶然性。因此，所提到的成本節約和協同效應可能無法實現，可能比估計的時間更晚或更早實現，或者實現的結果可能與估計的結果有重大差異。由於 Idox 集團的規模，可能會對 Idox 集團的運營產生額外變化。因此，考慮到這些變化與未來相關，最終的成本協同效應可能會大大高於或低於估計的水平。

Other than in accordance with their legal or regulatory obligations, neither Bidco nor Idox is under any obligation, and Bidco and Idox expressly disclaim any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

除非根據其法律或監管義務，Bidco 和 Idox 均不承擔任何義務，Bidco 和 Idox 明確聲明不打算或不承擔更新或修訂任何前瞻性聲明的義務，無論是由於新信息、未來事件還是其他原因。

Dealing and Opening Position Disclosure Requirements

交易和開盤頭寸披露要求

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Takeover Code applies must be made by no later than 3.30 pm (London time) on the 10th Business Day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

根據收購守則第 8.3(a) 條，任何對目標公司的相關證券或任何證券交換要約方（即任何非現金要約方）感興趣的個人，若其持有 1% 或以上的相關證券，必須在要約期開始後以及在首次識別任何證券交換要約方的公告後（如適用）進行開盤頭寸披露。開盤頭寸披露必須包含該個人在（i）目標公司和（ii）任何證券交換要約方的相關證券中的利益、空頭頭寸和認購權的詳細信息。根據收購守則第 8.3(a) 條的規定，相關個人必須在要約期開始後的第 10 個工作日的倫敦時間下午 3:30 之前進行開盤頭寸披露，並在首次識別任何證券交換要約方的公告後的第 10 個工作日的倫敦時間下午 3:30 之前（如適用）進行披露。在開盤頭寸披露截止日期之前，若相關個人在目標公司的相關證券或證券交換要約方的相關證券中進行交易，則必須進行交易披露。

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the Business Day following the date of the relevant dealing.

根據收購守則第 8.3(b) 條，任何對目標公司的相關證券或任何證券交換要約方感興趣的個人，若其持有 1% 或以上的相關證券，必須在其交易任何相關證券時進行交易披露。交易披露必須包含該交易的詳細信息以及該個人在（i）目標公司和（ii）任何證券交換要約方的相關證券中的利益、空頭頭寸和認購權的詳細信息，除非這些詳細信息已根據第 8 條提前披露。根據收購守則第 8.3(b) 條的規定，相關個人必須在相關交易發生後的工作日的倫敦時間下午 3:30 之前進行交易披露。

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

如果兩個或更多個人根據協議或理解（無論是正式還是非正式）共同採取行動，以獲取或控制對目標公司或證券交換要約方的相關證券的利益，他們將被視為根據第 8.3 條的規定為一個單一的個人。

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

開盤頭寸披露還必須由目標公司和任何要約方進行，交易披露還必須由目標公司、任何要約方以及與他們中的任何一方共同行動的任何個人進行（見第 8.1、8.2 和 8.4 條）。

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0) 20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

有關必須進行開盤頭寸披露和交易披露的受要約方和要約方公司的詳細信息，可以在小組網站 www.thetakeoverpanel.org.uk 的披露表中找到，包括相關證券的發行數量、要約期開始的時間以及首次識別的任何要約方的時間。如果您對是否需要進行開盤頭寸披露或交易披露有任何疑問，請聯繫小組的市場監測單位，電話是 +44 (0) 20 7638 0129。

Publication on a website

網站上的發佈

In accordance with Rule 26.1 of the Takeover Code, a copy of this announcement and the documents required to be published under Rule 26 of the Takeover Code will be made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Idox's website at www.idoxgroup.com/investors by no later than 12 noon (London time) on the Business Day following this announcement. For the avoidance of doubt, neither the content of this website nor of any website accessible from hyperlinks set out in this announcement is incorporated by reference or forms part of this announcement.

根據收購守則第 26.1 條的規定，本公告的副本及根據收購守則第 26 條要求發佈的文件將在 Idox 的網站 www.idoxgroup.com/investors 上提供，受限於與居住在限制管轄區的人員相關的某些限制，最遲在本公告發布後的工作日中午 12 點（倫敦時間）之前提供。為避免疑義，本網站的內容以及本公告中超鏈接所指向的任何網站的內容均不被視為引用或構成本公告的一部分。

No profit forecasts, estimates or quantified benefits statements

沒有利潤預測、估計或量化收益聲明

No statement in this announcement is intended as a profit forecast, profit estimate or quantified benefits statement for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Idox for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Idox.

本公告中的任何聲明均不意圖作為任何期間的利潤預測、利潤估計或量化收益聲明，本公告中的任何聲明不應被解釋為 Idox 在當前或未來財年中的收益或每股收益必然會與 Idox 歷史發佈的收益或每股收益相匹配或超過。

Requesting hard copy documents

請求紙質文件

In accordance with Rule 30.3 of the Takeover Code, Idox Shareholders, persons with information rights and participants in Idox Share Plans may request a hard copy of this announcement, free of charge, by contacting Neville Registrars on 0121 585 1131. You may also request that all future documents, announcements and information to be sent to you in relation to the Acquisition should be in hard copy form. Calls outside the U.K. will be charged at the applicable international rate. Lines are open between 8.30 a.m. and 5.30 p.m. (London time) Monday to Friday excluding public holidays in England and Wales. For persons who receive a copy of this announcement in electronic form or via a website notification, a hard copy of this announcement will not be sent unless so requested. In accordance with Rule 30.3 of the Takeover Code, such persons may also request that all future documents, announcements and information to be sent to them in relation to the Acquisition should be in hard copy form.

根據收購守則第 30.3 條，Idox 股東、擁有信息權利的人員和 Idox 股份計劃的參與者可以通過聯繫 Neville Registrars（電話：0121 585 1131）免費請求本公告的紙質副本。您還可以請求將與收購相關的所有未來文件、公告和信息以紙質形式發送給您。撥打英國以外的電話將按適用的國際費率收費。電話服務時間為週一至週五倫敦時間上午 8:30 至下午 5:30，公共假期除外。對於以電子形式或通過網站通知收到本公告的人員，除非請求，否則不會發送本公告的紙質副本。根據收購守則第 30.3 條，此類人員也可以請求將與收購相關的所有未來文件、公告和信息以紙質形式發送給他們。

Electronic communications

電子通訊

Please be aware that addresses, electronic addresses and certain other information provided by Idox Shareholders, persons with information rights and other relevant persons for the receipt of communications from Idox may be provided to Bidco during the offer period as required under Section 4 of Appendix 4 of the Takeover Code to comply with Rule 2.11(c) of the Takeover Code.

請注意，Idox 股東、擁有信息權利的人員及其他相關人員提供的用於接收 Idox 通訊的地址、電子地址及某些其他信息可能會在要約期間根據收購守則附錄 4 第 4 節的要求提供給 Bidco，以遵守收購守則第 2.11(c) 條。

Rounding

四捨五入

Certain figures included in this announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of figures that precede them.

本公告中包含的某些數字經過了四捨五入調整。因此，在不同表格中呈現的同一類別的數字可能會略有不同，並且在某些表格中顯示的總數可能不是前面數字的算術總和。

General

一般條款

The statements contained in this announcement are made as at the date of this announcement unless some other time is specified in relation to them, and service of this announcement shall not give rise to any implication that there has been no change in the facts set forth in this announcement since such date. Nothing in this announcement shall be deemed to be a forecast, projection or estimate of the future financial performance of HL or Bidco except where otherwise expressly stated.

本公告中包含的聲明是在本公告日期作出的，除非另有説明，否則不應推斷自該日期以來本公告中所述事實沒有變化。本公告中的任何內容不應被視為對 HL 或 Bidco 未來財務表現的預測、展望或估計，除非另有明確説明。

The Acquisition is subject to English law, the jurisdiction of the courts of England and Wales, and the applicable requirements of the Companies Act, the Takeover Code, the Panel, the London Stock Exchange and the FCA.

收購受英國法律、英格蘭和威爾士法院的管轄，以及《公司法》、《收購守則》、《小組》、《倫敦證券交易所》和 FCA 的適用要求的約束。

Bidco reserves the right to elect, with the consent of the Panel (where necessary) and subject to the terms of the Cooperation Agreement, to implement the Acquisition by way of an Offer as an alternative to the Scheme. In such an event, for so long as the Cooperation Agreement is continuing, an Offer will be implemented on substantially the same terms, so far as applicable, as those which would apply to the Scheme (subject to appropriate amendments, including an acceptance condition set at not more than 90 per cent. of the Idox Shares on a fully diluted basis (or such other percentage as may be permitted under the terms of the Cooperation Agreement) and (to the extent necessary) consultation with the Panel, being in any case more than 50 per cent. of the Idox Shares).

Bidco 保留在獲得小組同意（如有必要）並根據合作協議的條款實施收購的權利，作為對方案的替代方案。在這種情況下，只要合作協議持續有效，Offer 將在適用的情況下以與方案相同的實質條款實施（需適當修改，包括接受條件設定為不超過 Idox 股份的 90% 的完全攤薄基礎（或根據合作協議的條款可能允許的其他百分比），並且（在必要的情況下）與小組進行諮詢，且在任何情況下超過 Idox 股份的 50%。

If the Acquisition is effected by way of an Offer, and such an Offer becomes or is declared unconditional in all respects and sufficient acceptances are received, Bidco intends to exercise its rights to apply the provisions of Chapter 3 of Part 28 of the 2006 Act so as to acquire compulsorily the remaining Idox Shares in respect of which the Offer has not been accepted.

如果收購通過要約實施，並且該要約在所有方面變得或被宣佈為無條件，並且收到足夠的接受，Bidco 打算行使其權利，適用《2006 年法》第 28 部分第 3 章的條款，以強制收購未接受要約的剩餘 Idox 股份。

Investors should be aware that Bidco may purchase Idox Shares otherwise than under any Offer or the Scheme, including pursuant to privately negotiated purchases.

投資者應注意，Bidco 可能會以其他方式購買 Idox 股份，而不是通過任何要約或方案，包括根據私下協商的購買。

Rule 2.9 of the Takeover Code

收購守則第 2.9 條

For the purposes of Rule 2.9 of the Takeover Code, Idox confirms that, as at 27 October 2025, it had in issue 461,682,046 ordinary shares of 1 pence each admitted to trading on the Alternative Investment Market (AIM) of the London Stock Exchange. Idox does not hold any ordinary shares in treasury. The ISIN for the ordinary shares is GB0002998192.

根據收購守則第 2.9 條的規定，Idox 確認截至2025年10月27日，其已發行 461,682,046 股每股 1 便士的普通股，已在倫敦證券交易所的替代投資市場（AIM）上市交易。Idox 不持有任何普通股庫存。普通股的 ISIN 為 GB0002998192。

Disclaimer

免責聲明

The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, any security, and may not be used or relied upon in connection with any offer or solicitation. Any offer or solicitation in respect of Long Path will be made only through a confidential private placement memorandum and related documents which will be furnished to qualified investors on a confidential basis in accordance with applicable laws and regulations. The information contained herein is not for publication or distribution to persons in the U.S. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold without registration thereunder or pursuant to an available exemption therefrom. Any offering of securities to be made in the U.S. would have to be made by means of an offering document that would be obtainable from the issuer or its agents and would contain detailed information about the issuer of the securities and its management, as well as financial information. The securities may not be offered or sold in the U.S. absent registration or an exemption from registration.

本信息不構成出售任何證券的要約，也不構成購買任何證券的要約邀請，且不得在任何要約或邀請中使用或依賴。關於 Long Path 的任何要約或邀請將僅通過保密的私募備忘錄及相關文件進行，這些文件將根據適用法律法規以保密方式提供給合格投資者。本信息不適合在美國發布或分發。此處提及的任何證券尚未並將不會根據 1933 年美國證券法（經修訂）註冊，且在未註冊或根據可用豁免的情況下不得提供或出售。任何在美國進行的證券發行必須通過發行文件進行，該文件可從發行人或其代理處獲得，幷包含有關證券發行人及其管理層的詳細信息，以及財務信息。在未註冊或獲得豁免的情況下，這些證券不得在美國提供或出售。

The Acquisition will be subject to English law, the jurisdiction of the Court, and the applicable requirements of the Takeover Code, the Panel, the London Stock Exchange, the FCA, the AIM Rules and the Registrar of Companies.

此次收購將受英國法律、法院管轄權以及收購守則、面板、倫敦證券交易所、金融行為監管局、AIM 規則和公司註冊處的適用要求的約束。

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

此信息由倫敦證券交易所的新聞服務 RNS 提供。RNS 已獲得金融行為監管局的批准，作為英國的主要信息提供者。有關使用和分發此信息的條款和條件可能適用。如需更多信息，請聯繫 rns@lseg.com 或訪問 www.rns.com。

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END OUPLFLFBELLZFBK

RNS 可能會使用您的 IP 地址以確認遵守條款和條件，分析您與本通信中包含的信息的互動方式，並將此類分析以匿名方式與他人共享，作為我們商業服務的一部分。如需更多關於 RNS 和倫敦證券交易所如何使用您提供的個人數據的信息，請參見我們的隱私政策。END OUPLFLFBELLZFBK

REG - Long Path Partners IDOX PLC - 關於意向書的最新更新